At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 26 enrolled
Drug / intervention
carboplatin periocular injection +1 moredrug
Likely dose
carboplatin periocular injection 20mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CEV With/Without Periocular Carboplatin Chemotherapy for Nonmetastatic Extraocular Retinoblastoma Carboplatin--A Single Center, Retrospective Study to Evaluate the Efficacy of Carboplatin in Subjects With Retinoblastoma
In Brief
A Phase 4 clinical trial evaluating carboplatin periocular injection and CEV chemotherapy for Retinoblastoma. Completed, enrolled 26 participants.
Detailed Summary
This study will evaluate a uniform chemotherapy protocol for nonmetastatic extraocular retinoblastoma
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRetinoblastoma
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
Primary CompletionApr 2014
First PostedDec 2014
TodayJul 2026
First PostedDec 18, 2014
Enrollment StartJan 1, 2009
Primary CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 11.5 years ago
Interventions
carboplatin periocular injectiondrug
chemotherapy together with/without 20mg/2ml carboplatin periocular injection
CEV chemotherapydrug
vincristine,1.5mg/m2;carboplatin,560mg/ m2;etoposide,150 mg/ m2